Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 197 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Completed

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00453154

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +9 more
Locations
  • Arroyo Grande Community Arroyo Grande, California, United States
  • PCR Oncology Arroyo Grande, California, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States
View all 125 locations
View Trial Details
Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • Ocala Oncology Center Ocala, Florida, United States
  • Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04256421

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Rocky Mountain Cancer Centers - Lone Tree Lone Tree, Colorado, United States
  • MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center) Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists North Sarasota, Florida, United States
View all 121 locations
View Trial Details
Completed

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT04332653

Conditions
Adnexal Diseases, Any Advanced Solid Tumors, Breast Diseases, +41 more
Locations
  • Moffit Cancer Center Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions